Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tajikistan Health News.
Press releases published on July 24, 2025
American Kidney Fund Receives Major Gift from the Schattner Foundation to Bolster Regional Safety Net Grants and Support National Virtual Camp Program
GlobeNewswire
·
July 24, 2025
ROCKVILLE, Md., July 24, 2025 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) has received a $275,000 grant from the Rockville-based Schattner Foundation to provide greater financial assistance to people living with kidney failure in the District of …
Fat Burner for Women Launched Over the Counter: PhenQ Earns Medical Accreditation
GlobeNewswire
·
July 24, 2025
Albany, New York, July 24, 2025 (GLOBE NEWSWIRE) -- Women in search of a reliable, non-prescription fat burner now have a clinically trusted solution: PhenQ, a powerful over-the-counter (OTC) weight loss aid, has gained recognition from over 800 healthcare …
Vystar Introduces Ultrasoft Latex Mattress Topper with Vytex 55 Density Latex into the Vytex.com Store
GlobeNewswire
·
July 24, 2025
Ultrasoft 55 density Vytex foam topper created with breakthrough proprietary molding technology Provides luxuriously soft supportive comfort, resilience and breathability Transforms too-hard mattresses into snuggly comfort, ideal for pressure point relief …
PacBio HiFi Sequencing Powers First Arab Human Pangenome, Published in Nature Communications
GlobeNewswire
·
July 24, 2025
MENLO PARK, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced a significant advancement for global genomic equity. Researchers have published the …
Inspire Unveils Redesigned Site to Help Patients Navigate Health, Access Resources, and Find Support
GlobeNewswire
·
July 24, 2025
Arlington, VA, July 24, 2025 (GLOBE NEWSWIRE) -- Inspire, the world’s largest online community of patients and caregivers, has launched a major redesign of its platform to make it easier for people managing chronic and rare conditions to find support, …
Philips announces collaboration with Epic to enhance ambulatory cardiac monitoring
GlobeNewswire
·
July 24, 2025
July 24, 2025 Philips will now offer the largest cardiac care portfolio through Epic’s Aura platform CAMBRIDGE, Mass. – Royal Philips (NYSE: PHG, AEX: PHIA) a global leader in health technology, today announced a collaboration with Epic to integrate …
Kaleo’s AUVI-Q® (epinephrine injection, USP) Selected by Axiom Space to Help Protect Crew from Allergic Emergencies
GlobeNewswire
·
July 24, 2025
Richmond, Virginia, July 24, 2025 (GLOBE NEWSWIRE) -- Kaléo, a global leader in drug-delivery device technology and auto-injector innovation, today announced that AUVI-Q® (epinephrine injection, USP) was cleared for use as a part of Axiom Mission 4 that …
Outlook Therapeutics to Present at the 8th Annual Ophthalmology Innovation Summit (OIS) Retina Innovation Showcase
GlobeNewswire
·
July 24, 2025
ISELIN, N.J., July 24, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced that it will present at …
Hair Loss Awareness Month 2025 - “Time Equals Follicles”
GlobeNewswire
·
July 24, 2025
BOCA RATON, Fla., July 24, 2025 (GLOBE NEWSWIRE) -- As August marks Hair Loss Awareness Month, renowned Hair Restoration Surgeon Dr. Alan J. Bauman continues his decades-long mission of educating the public on breakthrough treatments for hair preservation …
BioCardia Submits Request for Clinical Data Review Meeting with Japan PMDA To Discuss Approval Pathway for CardiAMP® Cell Therapy in Ischemic Heart Failure
GlobeNewswire
·
July 24, 2025
SUNNYVALE, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [NASDAQ:BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, announced today that it submitted its CardiAMP …
Windtree Therapeutics Announces Up To $520 Million in New Funding to Amplify BNB Cryptocurrency Treasury Strategy
GlobeNewswire
·
July 24, 2025
Up to $700 Million Committed to BNB Acquisitions, Reinforcing Innovative Crypto Treasury Strategy Ninety Nine Percent of the proceeds from both issuances to be used to buy BNB WARRINGTON, Pa., July 24, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. …
Gain Therapeutics to Present at BTIG Annual Virtual Biotechnology Conference
GlobeNewswire
·
July 24, 2025
BETHESDA, Md., July 24, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next-generation of allosteric small molecule therapies, …
Digital Utilities Ventures, Inc. Announces the Addition of New Sales Operations Manager to Easy Environmental Solutions, Inc
GlobeNewswire
·
July 24, 2025
Nick Vincent Joins Easy Environmental Solutions as Sales Operations Manager Digital Utilities Ventures, Inc. (OTC: DUTV), doing business as Easy Environmental Solutions Inc., has appointed Nick Vincent as its new Sales Operations Manager. Vincent brings a …
Abivax announces trading resumption of its ordinary shares on Euronext Paris
GlobeNewswire
·
July 24, 2025
Abivax announces trading resumption of its ordinary shares on Euronext Paris PARIS, France, July 24, 2025 – 02:30 p.m. (CEST) – Abivax SA (Euronext Paris: FR0012333284 – ABVX) (“Abivax” or the “Company”), a clinical-stage biotechnology company focused on …
Abivax Announces Pricing of $650M (€554M) Public Offering of American Depositary Shares
GlobeNewswire
·
July 24, 2025
Abivax Announces Pricing of $650M (€554M) Public Offering of American Depositary Shares PARIS, France, July 24, 2025 – 2:30 p.m. (CEST) – Abivax SA (Euronext Paris: FR0012333284 – ABVX) (“Abivax” or the “Company”), a clinical-stage biotechnology company …
Mersana Therapeutics Announces 1-for-25 Reverse Stock Split
GlobeNewswire
·
July 24, 2025
CAMBRIDGE, Mass., July 24, 2025 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on the development of antibody-drug conjugates (ADCs) targeting cancers in areas of high unmet medical need, …
Liminatus Pharma Inc. Takes Next Step in Evaluating Digital Asset-Linked Capital Strategy
GlobeNewswire
·
July 24, 2025
LA PALMA, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- Liminatus Pharma, Inc. (NASDAQ: LIMN), a preclinical-stage biopharmaceutical company dedicated to the development of targeted cancer immunotherapies, today announced it has entered into an engagement …
ICU Medical Announces Time of Second Quarter 2025 Earnings Conference Call
GlobeNewswire
·
July 24, 2025
SAN CLEMENTE, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its second quarter 2025 earnings release and conference …
Achieve Life Sciences to Announce Second Quarter Financial Results and Host Conference Call and Webcast on August 7, 2025
GlobeNewswire
·
July 24, 2025
SEATTLE and VANCOUVER, British Columbia, July 24, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of …
iSpecimen Inc. Announces Pricing of $4 Million Underwritten Offering
GlobeNewswire
·
July 24, 2025
WOBURN, Mass., July 24, 2025 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers …